Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 5Leukemia 4Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 4Vincristine 2Thioguanine 2Prednisolone 2Mitoxantrone 2Methotrexate 2Mercaptopurine 2Melphalan 2Leucovorin 2Hydrocortisone 2Etoposide 2Daunorubicin 2Cytarabine 2Cord Blood Stem Cell Transplantation 2Asparaginase 2sargramostim 1pegaspargase 1fludarabine phosphate 1Whole-Body Irradiation 1Vindesine 1Therapeutics 1Tacrolimus 1Rituximab 1Psychiatric Rehabilitation 1Prednisone 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Biphenotypic, Acute × Vindesine × Clear all
NCT00003728 2011-01-21

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,500 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡